Cash & equivalents increased 68.7%
Cash & equivalents changed +68.7% from the comparable as-filed period.
$179.3M→$302.5M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CGNX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 325 bp higher
Gross margin changed +325 basis points from the comparable as-filed period.
67.39%→70.65%3 prior comparisons
Gross profit increased 22.6%
Gross profit changed +22.6% from the comparable as-filed period.
$167.9M→$205.8M3 prior comparisons
Net income increased 79.6%
Net income changed +79.6% from the comparable as-filed period.
$40.5M→$72.8M3 prior comparisons
Operating income increased 96.9%
Operating income changed +96.9% from the comparable as-filed period.
$43.4M→$85.5M3 prior comparisons
Operating margin moved 1192 bp higher
Operating margin changed +1192 basis points from the comparable as-filed period.
17.44%→29.36%3 prior comparisons
Revenue increased 16.9%
Revenue changed +16.9% from the comparable as-filed period.
$249.1M→$291.3M3 prior comparisons
Stock-based compensation decreased 8.8%
Stock-based compensation changed -8.8% from the comparable as-filed period.
$12.3M→$11.2M3 prior comparisons
Inventory decreased 1.2%
Inventory changed -1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$144.6M→$142.8M4 prior comparisons
Research & development decreased 2.1%
Research & development changed -2.1% from the comparable as-filed period.
$33.1M→$32.4M3 prior comparisons
Selling, general & administrative decreased 3.8%
Selling, general & administrative changed -3.8% from the comparable as-filed period.
$91.3M→$87.9M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.